vTv Therapeutics Inc.
VTVT
$33.28
-$0.43-1.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.94% | -43.86% | -18.74% | -40.12% | 24.02% |
| Total Depreciation and Amortization | 0.00% | -33.33% | -66.67% | -59.09% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 291.33% | -27.66% | -76.03% | -6,575.00% | 98.91% |
| Change in Net Operating Assets | -180.09% | 187.31% | 520.77% | 72.13% | 6.35% |
| Cash from Operations | -77.15% | -2.49% | 10.41% | -17.87% | 24.82% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -412.50% | -- | -- | -- | -- |
| Issuance of Common Stock | -99.99% | 860,744.44% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.41% | 185,347.62% | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -113.19% | 1,512.93% | 9.67% | -17.87% | -22.00% |